Sound Pharmaceuticalsinc Spiis A Biopharmaceutical Company Based In Seattlewashingtonestablished In 2002The Company Is Dedicated To Developing Therapeutics For Sensorineural Otologic Diseasesfocusing On Hearing Loss And Tinnituswhich Affect Millions Of Americansspi Operates In The Pharmaceutical Manufacturing Sectorspecializing In Drugs That Target The Central And Peripheral Nervous Systems Spi S Pipeline Includes Several Promising Candidatesspi 1005 Is A Small Molecule Drug That Has Shown Significant Results In Treating Meniereae S Disease And Noise Induced Hearing Lossit Has Completed Multiple Studies With Over 800 Patientsother Candidates Include Spi 3005Aimed At Reducing Chemotherapy Related Hearing Damageand Spi 5557Which Targets Severe To Profound Hearing Impairmentthe Company Holds Nine Patents Related To Its Research And Development Effortsprimarily In Otologic Therapeutics
